Follow
Christophe Macri
Christophe Macri
Verified email at unimelb.edu.au
Title
Cited by
Cited by
Year
HSPA8/HSC70 chaperone protein: structure, function, and chemical targeting
F Stricher, C Macri, M Ruff, S Muller
Autophagy 9 (12), 1937-1954, 2013
3572013
Dendritic cell subsets
C Macri, ES Pang, T Patton, M O’Keeffe
Seminars in cell & developmental biology 84, 11-21, 2018
2302018
Targeting dendritic cells: a promising strategy to improve vaccine effectiveness
C Macri, C Dumont, APR Johnston, JD Mintern
Clinical & translational immunology 5 (3), e66, 2016
1962016
Dendritic cells and cancer: from biology to therapeutic intervention
B Wylie, C Macri, JD Mintern, J Waithman
Cancers 11 (4), 521, 2019
1292019
Differential use of autophagy by primary dendritic cells specialized in cross-presentation
JD Mintern, C Macri, WJ Chin, SE Panozza, E Segura, NL Patterson, ...
Autophagy 11 (6), 906-917, 2015
1002015
Modulation of deregulated chaperone-mediated autophagy by a phosphopeptide
C Macri, F Wang, I Tasset, N Schall, N Page, JP Briand, AM Cuervo, ...
Autophagy 11 (3), 472-486, 2015
932015
Criteria for dendritic cell receptor selection for efficient antibody-targeted vaccination
A Reuter, SE Panozza, C Macri, C Dumont, J Li, H Liu, E Segura, ...
The Journal of Immunology 194 (6), 2696-2705, 2015
812015
Peptide-based approaches to treat lupus and other autoimmune diseases
N Schall, N Page, C Macri, O Chaloin, JP Briand, S Muller
Journal of autoimmunity 39 (3), 143-153, 2012
612012
Modulation of antigen presentation by intracellular trafficking
JD Mintern, C Macri, JA Villadangos
Current opinion in immunology 34, 16-21, 2015
452015
Epstein–Barr virus protein EB2 stimulates cytoplasmic mRNA accumulation by counteracting the deleterious effects of SRp20 on viral mRNAs
F Juillard, Q Bazot, F Mure, L Tafforeau, C Macri, C Rabourdin-Combe, ...
Nucleic acids research 40 (14), 6834-6849, 2012
382012
Adamantane-based dendrons for trimerization of the therapeutic P140 peptide
G Lamanna, M Grillaud, C Macri, O Chaloin, S Muller, A Bianco
Biomaterials 35 (26), 7553-7561, 2014
212014
Targeting dendritic cells to advance cross-presentation and vaccination outcomes
C Macri, D Jenika, C Ouslinis, JD Mintern
Seminars in Immunology 68, 101762, 2023
162023
Therapeutic inhibition of the SRC-kinase HCK facilitates T cell tumor infiltration and improves response to immunotherapy
AR Poh, CG Love, D Chisanga, JH Steer, D Baloyan, M Chopin, S Nutt, ...
Science advances 8 (25), eabl7882, 2022
162022
Antibody-mediated targeting of antigen to C-type lectin-like receptors Clec9A and Clec12A elicits different vaccination outcomes
C Macri, C Dumont, S Panozza, MH Lahoud, I Caminschi, JA Villadangos, ...
Molecular Immunology 81, 143-150, 2017
152017
Ubiquitin-like protein 3 (UBL3) is required for MARCH ubiquitination of major histocompatibility complex class II and CD86
H Liu, KR Wilson, AM Firth, C Macri, P Schriek, AB Blum, J Villar, ...
Nature communications 13 (1), 1934, 2022
132022
Monitoring dendritic cell activation and maturation
C Macri, B Fancke, KJ Radford, M O’Keeffe
Antigen Processing: Methods and Protocols, 403-418, 2019
132019
Regulation of dendritic cell function by Fc-γ-receptors and the neonatal Fc receptor
C Macri, H Morgan, JA Villadangos, JD Mintern
Molecular Immunology 139, 193-201, 2021
122021
MHC class II ubiquitination regulates dendritic cell function and immunity
KR Wilson, D Jenika, AB Blum, C Macri, B Xu, H Liu, P Schriek, ...
The Journal of Immunology 207 (9), 2255-2264, 2021
112021
Discordance in STING-induced activation and cell death between mouse and human dendritic cell populations
ES Pang, G Daraj, KR Balka, D De Nardo, C Macri, H Hochrein, ...
Frontiers in Immunology 13, 794776, 2022
92022
Ubiquitination of MHC class II is required for development of regulatory but not conventional CD4+ T cells
H Liu, KR Wilson, P Schriek, C Macri, AB Blum, L Francis, M Heinlein, ...
The Journal of Immunology 205 (5), 1207-1216, 2020
92020
The system can't perform the operation now. Try again later.
Articles 1–20